Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Income towards Parent Company: 2016-2025

Historic Income towards Parent Company for Rocket Pharmaceuticals (RCKT) over the last 10 years, with Sep 2025 value amounting to -$52.0 million.

  • Rocket Pharmaceuticals' Income towards Parent Company rose 24.15% to -$52.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$248.2 million, marking a year-over-year increase of 7.45%. This contributed to the annual value of -$266.8 million for FY2024, which is 4.13% down from last year.
  • Latest data reveals that Rocket Pharmaceuticals reported Income towards Parent Company of -$52.0 million as of Q3 2025, which was up 26.89% from -$71.1 million recorded in Q2 2025.
  • Rocket Pharmaceuticals' 5-year Income towards Parent Company high stood at -$33.8 million for Q2 2021, and its period low was -$71.9 million during Q2 2024.
  • Over the past 3 years, Rocket Pharmaceuticals' median Income towards Parent Company value was -$64.2 million (recorded in 2023), while the average stood at -$64.5 million.
  • Within the past 5 years, the most significant YoY rise in Rocket Pharmaceuticals' Income towards Parent Company was 27.53% (2021), while the steepest drop was 71.22% (2021).
  • Quarterly analysis of 5 years shows Rocket Pharmaceuticals' Income towards Parent Company stood at -$43.9 million in 2021, then crashed by 55.43% to -$68.3 million in 2022, then grew by 7.86% to -$62.9 million in 2023, then climbed by 2.20% to -$61.5 million in 2024, then increased by 24.15% to -$52.0 million in 2025.
  • Its Income towards Parent Company stands at -$52.0 million for Q3 2025, versus -$71.1 million for Q2 2025 and -$63.5 million for Q1 2025.